Detalhe da pesquisa
1.
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Lancet Oncol
; 23(8): 1066-1077, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839786
2.
A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy.
Br J Haematol
; 188(3): 404-412, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31468521
3.
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study.
Lancet Oncol
; 19(4): 486-496, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475723
4.
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.
Cancer
; 123(6): 994-1002, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28094841
5.
Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.
Br J Haematol
; 177(2): 254-262, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28169430
6.
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia.
Oncologist
; 22(10): 1156-e111, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687625
7.
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study.
Am J Hematol
; 97(1): E24-E27, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731510
8.
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma.
Haematologica
; 100(5): 670-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25710456
9.
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Leukemia
; 38(1): 58-66, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935977
10.
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease.
J Clin Oncol
; 39(17): 1888-1898, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33877856
11.
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies.
Blood Adv
; 5(23): 5332-5343, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547767
12.
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study.
Clin Cancer Res
; 26(9): 2096-2103, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31964785
13.
Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.
JCO Oncol Pract
; 16(6): e464-e475, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048933
14.
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 18(8): e327-e331, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29934062
15.
Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.
J Clin Oncol
; 33(33): 3921-9, 2015 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26056177
16.
Medulloblastoma in an Adult With Late Extraneural Metastases to the Mediastinum.
J Investig Med High Impact Case Rep
; 2(2): 2324709614532798, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-26425604
17.
Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.
Biol Blood Marrow Transplant
; 13(12): 1422-6, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18022571
18.
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.
Biol Blood Marrow Transplant
; 11(3): 188-93, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15744237
19.
Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.
Gynecol Oncol
; 95(3): 506-12, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15581954